Division of Cellular Therapy
|Location||General Research Building 5F|
We are mainly committed to basic studies on hematopoietic tumor, normal hematopoiesis and leukemic stem cells. Current efforts focus on elucidating the fundamental role of epigenetic alteration in hematopoietic malignancies, developing new treatment strategies with mouse models of hematopoietic tumor, and unraveling the detailed molecular mechanism of hematopoietic stem cell replication and differentiation. We also challenge the development of novel experimental tools, such as G0 marker mouse and cell cycle counter.